Genzyme Corp. (NASDAQ: GENZ), at an analyst day meeting today, reaffirmed its its goal of $7 billion in annual revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE